Related Experiment Video
Updated: Jan 5, 2026

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Bioinspired artificial platelets for transfusion applications in traumatic hemorrhage
Aditya Girish1, Ujjal Sekhon1, Anirban Sen Gupta1
1Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio.
Platelets (PLTs) face transfusion challenges due to short shelf life and logistics. Research is developing biologic, biosynthetic, and artificial PLTs to improve availability and trauma survival.
Area of Science:
- Biomedical Engineering
- Hematology
- Transfusion Medicine
Background:
- Platelets (PLTs) are critical blood components for hemostasis.
- Current transfusion practices face significant logistical hurdles including limited availability, storage difficulties, contamination risks, and a short shelf life of approximately 5 days.
- These challenges impact timely transfusion, especially in trauma care.
Purpose of the Study:
- To address the critical limitations of platelet transfusion.
- To explore innovative solutions for enhancing platelet availability and accessibility.
- To investigate the development of alternative platelet therapies.
Main Methods:
- Reviewing current research on in vitro biologic platelet production.
- Examining the design and development of biosynthetic platelet substitutes.
- Analyzing the creation of artificial platelet technologies.
- Assessing the potential of these novel approaches to overcome logistical challenges.
Main Results:
- Biologic PLTs developed in vitro show promise for increased availability.
- Biosynthetic and artificial PLT technologies are emerging as potential solutions.
- These advanced technologies aim to mitigate storage, contamination, and shelf-life issues.
- Successful development could significantly improve transfusion capabilities.
Conclusions:
- Developing alternative platelet sources is crucial for transfusion medicine.
- In vitro biologic, biosynthetic, and artificial PLTs offer potential solutions to current limitations.
- These innovations are expected to enhance patient survival, particularly in emergency settings like trauma.
- Further research and development are essential for clinical translation.
More Related Videos
10:25Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
Published on: March 19, 2016
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
Related Concept Videos
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...